DCLK1 immunoreactivity in colorectal neoplasia

Clinical and Experimental Gastroenterology

Volumn 5, Issue 1, 2012, Pages 35-42

  Gagliardi, Giuseppe ^a   Goswami, Monica ^a   Passera, Roberto ^b   Bellows, Charles F ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Nuclear Medicine   (Italy)

Author keywords

Adenomatous polyps; Cancer stem cell; DCAMKL 1; DCLK1; Gastrointestinal stem cell; Immunohistochemistry; Liver metastasis

Indexed keywords

BIOLOGICAL MARKER; DOUBLECORTIN AND CAM KINASE LIKE 1; PROTEIN KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CARCINOMA IN SITU; COLON POLYPOSIS; COLORECTAL CARCINOMA; COLORECTAL SURGERY; COLORECTAL TUMOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; DYSPLASIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE COMPLICATION; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 84860792359     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S30281     Document Type: Article

References (24)

1. Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell. 2009;138(5):822-829.
2. Barker N, Ridgway RA, van Es JH, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457(7229):608-611.
3. Todaro M, Francipane MG, Medema J P, Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology. 2010;138(6): 2151-2162.
4. Lin PT, Gleeson JG, Corbo JC, Flanagan L, Walsh CA. DCAMKL1 encodes a protein kinase with homology to doublecortin that regulates microtubule polymerization. J Neurosci. 2000;20(24):9152-9161.
5. Giannakis M, Stappenbeck TS, Mills JC, et al. Molecular properties of adult mouse gastric and intestinal epithelial progenitors in their niches. J Biol Chem. 2006;281(16):11292-11300.
6. May R, Sureban SM, Hoang N, et al. Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively. Stem Cells. 2009;27(10):2571-2579.
7. Sureban SM, May R, Ramalingam S, et al. Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism. Gastroenterology. 2009;137(2):649-659, e641-e642.
8. Vega KJ, May R, Sureban SM, et al. Identification of the putative intestinal stem cell marker DCAMKL-1 in Barrett's esophagus and esophageal adenocarcinoma. J Gastroenterol Hepatol. 2011.
9. Sureban SM, May R, Lightfoot SA, et al. DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Res. 2011;71(6):2328-2338.
10. Becker L, Huang Q, Mashimo H. Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus. 2010;23(2):168-174.
11. Fan XS, Wu HY, Yu HP, Zhou Q, Zhang YF, Huang Q. Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin. Int J Colorectal Dis. 2010;25(5):583-590.
12. Takeda K, Kinoshita I, Shimizu Y, Matsuno Y, Shichinohe T, Dosaka-Akita H. Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Anticancer Res. 2011;31(1):263-270.
13. Bjerknes M, Khandanpour C, Möröy T, et al. Origin of the brush cell lineage in the mouse intestinal epithelium. Dev Biol. 2012;362(2):194-218.
14. Sureban SM, May R, Mondalek FG, et al. Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. J N anobiotechnology. 2011;9(1):40.
15. Wong WM, Mandir N, Goodlad RA, et al. Histogenesis of human col-orectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut. 2002;50(2):212-217.
16. Shamsuddin AK, Weiss L, Phelps PC, Trump BF. Colon epithelium. I V. Human colon carcinogenesis. Changes in human colon mucosa a djacent to and remote from carcinomas of the colon. J Natl Cancer Inst. 1981;66(2):413-419.
17. Dawson PA, Filipe MI. An ultrastructural and histochemical study of the mucous membrane adjacent to and remote from carcinoma of the colon. Cancer. 1976;37(5):2388-2398.
18. Riddell RH, Levin B. Ultrastructure of the "transitional" mucosa adjacent to large bowel carcinoma. Cancer. 1977;40(Suppl 5):2509-2522.
19. Kuniyasu H, Yasui W, Shinohara H, et al. Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am J Pathol. 2000;157(5):1523-1535.
20. Humphries A, Wright NA. Colonic crypt organization and tumorigenesis. Nat Rev Cancer. 2008;8(6):415-424.
21. Kleist B, Xu L, Li G, Kersten C. Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer. Int J Clin Exp Pathol. 2011;4(4):327-335.
22. Merlos-Suárez A, Barriga FM, Jung P, et al. The intestinal stem cell signature identifes colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell. 2011;8(5):511-524.
23. Li D, Peng X, Ya n D, et al. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer. Ann Surg Oncol. 2011;18(7): 2074-2083.
24. Takahashi H, Ishii H, Nishida N, et al. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Ann Surg Oncol. 2011;18(4): 1166-1174.